FSD Pharma surges on shifting focus to potential COVID-19 treatment
30/07/2020 14:38
** U.S.-listed shares of Canadian pharma co HUGE.O surge
43.3% to $5.4, set for the best day in over a month
** Says it has notified Health Canada of its decision to
forfeit the licenses of its cannabis unit, FV Pharma Inc, and
suspend all activities within 30 days urn:newsml:reuters.com:*:nACSbS85Ha
** Adds its now focusing on starting mid-stage clinical
trials of its experimental drug to treat hospitalized COVID-19
patients before the end of this year
** Co has started liquidating all FV Pharma assets,
including co's cannabis production facility in Cobourg, Ontario
** Stock down 29.3% this year, as of last close
(Reporting by Dania Nadeem in Bengaluru)
((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3463;))